Interaction between the antidepressant-like behavioral effects of beta adrenergic agonists and the cyclic AMP PDE inhibitor rolipram in rats

Psychopharmacology

Volumn 182, Issue 1, 2005, Pages 104-115

  Zhang, Han Ting ^a   Huang, Ying ^a   Mishler, Kathleen ^a   Roerig, Sandra C ^b   O'Donnell, James M ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Antidepressant; Beta adrenergic receptors; Clenbuterol; Cyclic AMP; Differential reinforcement of low rate (DRL); Dobutamine; Drug discrimination; Isobole; Phosphodiesterase (PDE4); Rolipram

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLENBUTEROL; DOBUTAMINE; PHOSPHODIESTERASE IV INHIBITOR; ROLIPRAM;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BRAIN CORTEX; BRAIN DEPTH STIMULATION; BRAIN NERVE CELL; CELL CULTURE; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; MALE; NONHUMAN; PERCEPTIVE DISCRIMINATION; PRIORITY JOURNAL; RAT; REINFORCEMENT; SIGNAL TRANSDUCTION;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ADRENERGIC BETA-AGONISTS; ANIMALS; ANTIDEPRESSIVE AGENTS; APPETITIVE BEHAVIOR; CELLS, CULTURED; CEREBRAL CORTEX; CLENBUTEROL; CYCLIC AMP; DISCRIMINATION LEARNING; DOBUTAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; INJECTIONS, INTRAPERITONEAL; MALE; NEURONS; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT SCHEDULE; ROLIPRAM; SIGNAL TRANSDUCTION;

EID: 25844486653     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-0055-y     Document Type: Article

References (45)

1. Baker SP, Sumners C, Pitha J, Raizada MK (1986) Characteristics of the beta adrenoreceptor from neuronal and glial cells in primary cultures of rat brain. J Neurochem 47:1318-1326
2. Crissman AM, Makhay MM, O'Donnell JM (2001) Discriminative stimulus effects of centrally administered isoproterenol in rats: mediation by beta-1 adrenergic receptors. Psychopharmacology (Berl) 154:70-75
3. Crissman AM, O'Donnell JM (2002) Effects of antidepressants in rats trained to discriminate centrally administered isoproterenol. J Pharmacol Exp Ther 302:606-611
4. Finnegan KT, Terwilliger MM, Berger PA, Hollister LE, Csernansky JG (1987) A comparison of the neurochemical and behavioral effects of clenbuterol and desipramine. Eur J Pharmacol 134:131-136
5. Fujita H, Tanaka J, Maeda N, Sakanaka M (1998) Adrenergic agonists suppress the proliferation of microglia through beta 2-adrenergic receptor. Neurosci Lett 242:37-40
6. Green SA, Holt BD, Liggett SB (1992) Beta 1- and beta 2-adrenergic receptors display subtype-selective coupling to Gs. Mol Pharmacol 41:889-893
7. Guerrero SW, Zhong H, Minneman KP (1995) Selective desensitization of beta 1- and beta 2-adrenergic receptors in C6 glioma cells. Effects on catecholamine responsiveness. Receptor 5: 185-195
8. Gurguis GN, Vo SP, Griffith JM, Rush AJ (1999) Neutrophil beta (2)-adrenoceptor function in major depression: G(s) coupling, effects of imipramine and relationship to treatment outcome. Eur J Pharmacol 386:135-144
9. Hichami A, Boichot E, Germain N, Legrand A, Moodley I, Lagente V (1995) Involvement of cyclic AMP in the effects of phosphodiesterase IV inhibitors on arachidonate release from mononuclear cells. Eur J Pharmacol 291:91-97
10. Kimmel HL, Tallarida RJ, Holtzman SG (1997) Synergism between buprenorphine and cocaine on the rotational behavior of the nigrally-lesioned rat. Psychopharmacology (Berl) 133:372-377
11. Lacoste A, Malham SK, Cueff A, Poulet SA (2001) Noradrenaline modulates oyster hemocyte phagocytosis via a beta-adrenergic receptor-cAMP signaling pathway. Gen Comp Endocrinol 122:252-259
12. Lecrubier Y, Puech AJ, Frances H, Jouvent R, Widlocher D, Simon P (1981) Beta-adrenergic stimulation and antidepressant activity. Acta Psychiatr Scand Suppl 290:173-178
13. Laemont KD, Schaefer CJ, Juneau PL, Schrier DJ (1999) Effects of the phosphodiesterase inhibitor rolipram on streptococcal cell wall-induced arthritis in rats. Int J Immunopharmacol 21:711-725
14. Levitzki A (1988) From epinephrine to cyclic AMP. Science 241:800-806
15. Levy FO, Zhu X, Kaumann AJ, Birnbaumer L (1993) Efficacy of beta 1-adrenergic receptors is lower than that of beta 2-adrenergic receptors. Proc Natl Acad Sci U S A 90:10798-10802
16. Makhay MM, Houslay MD, O'Donnell JM (2001) Discriminative stimulus effects of the type-4 phosphodiesterase inhibitor rolipram in rats. Psychopharmacology (Berl) 158:297-304
17. Morin D, Sapena R, Tillement JP, Urien S (2000) Evidence for different interactions between beta(1)- and beta(2)-adrenoceptor subtypes with adenylyl cyclase in the rat brain: a concentration-response study using forskolin. Pharmacol Res 41:435-443
18. Murugaiah KD, O'Donnell JM (1995a) Facilitation of noradrenaline release from rat brain slices by β-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 351:483-490
19. Murugaiah KD, O'Donnell JM (1995b) Facilitation of norepinephrine release from cerebral cortex is mediated by beta2-adrenergic receptors. Life Sci 57:PL327-PL332
20. O'Donnell JM (1988) Psychopharmacological consequences of activation of beta adrenergic receptors by SOM-1122. J Pharmacol Exp Ther 246:38-46
21. O'Donnell JM (1990) Behavioral effects of beta adrenergic agonists and antidepressant drugs after down-regulation of beta-2 adrenergic receptors by clenbuterol. J Pharmacol Exp Ther 254:147-157
22. O'Donnell JM (1993) Effects of the beta-2 adrenergic agonist zinterol on DRL behavior and locomotor activity. Psychopharmacology (Berl) 113:89-94
23. O'Donnell JM, Frith S (1999) Behavioral effects of family-selective inhibitors of cyclic nucleotide phosphodiesterases. Pharmacol Biochem Behav 63:185-192
24. O'Donnell JM, Zhang HT (2004) Antidepressant effects of inhibitors of cyclic AMP phosphodiesterase (PDE4). Trends Pharmacol Sci (TIPS) 25:158-163
25. O'Donnell JM, Frith S, Wilkins J (1994) Involvement of beta-1 and beta-2 adrenergic receptors in the antidepressant-like effects of centrally administered isoproterenol. J Pharmacol Exp Ther 271:246-254
26. O'Donnell JM, Marek GJ, Seiden LS (2005) Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low-rate (DRL) operant schedule. Neurosci Biobehav Rev, in press
27. Ordway GA, O'Donnell JM, Frazer A (1987) Effects of clenbuterol on central beta-1 and beta-2 adrenergic receptors of the rat. J Pharmacol Exp Ther 241:187-195
28. Ordway GA, Gambarana C, Frazer A (1988) Quantitative autoradiography of central beta adrenoceptor subtypes: comparison of the effects of chronic treatment with desipramine or centrally administered 1-isoproterenol. J Pharmacol Exp Ther 247:379-389
29. Paetsch PR, Greenshaw AJ (1993) Effects of chronic antidepressant treatment on beta-adrenoceptor subtype binding in the rat cerebral cortex and cerebellum. Mol Chem Neuropathol 20:21-31
30. Perez J, Tardito D, Mori S, Racagni G, Smeraldi E, Zanardi R (2000) Abnormalities of cAMP signaling in affective disorders: implication for pathophysiology and treatment. Bipolar Disord 2:27-36
31. Rainbow TC, Parsons B, Wolfe BB (1984) Quantitative autoradiography of β1- and β2-adrenergic receptors in rat cerebellum and cerebral cortex. Proc Natl Acad Sci U S A 81:1585-1589
32. Rothwell NJ, Stock MJ, Sudera DK (1987) Changes in tissue blood flow and beta-receptor density of skeletal muscle in rats treated with the beta2-adrenoceptor agonist clenbuterol. Br J Pharmacol 90:601-607
33. Tallarida RJ (2002) The interaction index: a measure of drug synergism. Pain 98:163-168
34. Tanaka KF, Kashima H, Suzuki H, Ono K, Sawada M (2002) Existence of functional beta1- and beta2-adrenergic receptors on microglia. J Neurosci Res 70:232-237
35. Teixeira MM, Rossi AG, Giembycz MA, Hellewell PG (1996) Effects of agents which elevate cyclic AMP on guinea-pig eosinophil homotypic aggregation. Br J Pharmacol 11:2099-2106
36. Van Lambalgen AA, van Kraats AA, Mulder MF, van den Bos GC, Teerlink T, Thijs LG (1993) Organ blood flow and distribution of cardiac output in dopexamine- or dobutamine-treated endotoxemic rats. J Crit Care 8:117-127
37. Wei ZY, Karim F, Roerig SC (1996) Spinal morphine/clonidine antinociceptive synergism: involvement of G proteins and N-type voltage-dependent calcium channels. J Pharmacol Exp Ther 278:1392-1407
38. Yamashita N, Yamauchi M, Baba J, Sawa A (1997) Phosphodiesterase type 4 that regulates cAMP level in cortical neurons shows high sensitivity to rolipram. Eur J Pharmacol 337:95-102
39. Ye Y, O'Donnell JM (1996) Diminished noradrenergic stimulation reduces the activity of rolipram-sensitive, high-affinity cyclic AMP phosphodiesterase in rat cerebral cortex. J Neurochem 66:1894-1902
40. Ye Y, Conti M, Houslay MD, Farooqui SM, Chen M, O'Donnell JM (1997) Noradrenergic activity differentially regulates the expression of rolipram-sensitive, high-affinity cyclic AMP phosphodiesterase (PDE4) in rat brain. J Neurochem 69:2397-2404
41. Yoshimura T, Kurita C, Nagao T, Usami E, Nakao T, Watanabe S, Kobayashi J, Yamazaki F, Tanaka H, Nagai H (1997) Effects of cAMP-phosphodiesterase isozyme inhibitor on cytokine production by lipopolysaccharide-stimulated human peripheral blood mononuclear cells. Gen Pharmacol 29:633-638
42. Zhang HT, Crissman AM, Dorairaj NR, Chandler LJ, O'Donnell JM (2000) Inhibition of cyclic AMP phosphodiesterase (PDE4) reverses memory deficits associated with NMDA receptor antagonism. Neuropsychopharmacology 23:198-204
43. Zhang HT, Frith SA, Wilkins J, O'Donnell JM (2001) Comparison of the effects of isoproterenol administered into the hippocampus, frontal cortex, or amygdala on behavior of rats maintained by differential reinforcement of low response rate. Psychopharmacology (Berl) 159:89-97
44. Zhang HT, Huang Y, Jin SL, Frith SA, Suvarna N, Conti M, O'Donnell JM (2002) Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme. Neuropsychopharmacology 27:587-595
45. Zhang HT, Huang Y, O'Donnell JM (2003) Antagonism of the antidepressant-like effects of clenbuterol by central administration of beta-adrenergic antagonists in rats. Psychopharmacology (Berl) 170:102-107